Methylene Blue Is an Effective Disclosing Agent for Identifying Bacterial Biofilms on Orthopaedic Implants

Jeremy D Shaw1,2, Darrel S Brodke1, Dustin L Williams1,3,4,5

  • 1Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, Utah.

Abstract

Insights

Methylene blue (MB) effectively visualizes bacterial biofilms on implants in vitro. This dye aids in identifying biofilms on common implant materials without staining healthy tissues, potentially improving surgical debridement.

Area of Science:

  • Biomaterials science
  • Microbiology
  • Medical imaging

Background:

  • Bacterial biofilms present a significant challenge in treating implant-associated infections due to their resistance to antimicrobials and host defenses.
  • Methylene blue (MB) has shown potential as a biofilm-disclosing agent, but requires rigorous in vitro validation.
  • Current diagnostic methods often fail to detect biofilms, which are typically invisible to the naked eye.

Purpose of the Study:

  • To evaluate methylene blue (MB) as an in vitro biofilm-disclosing agent for common biofilm-forming bacteria.
  • To assess the performance characteristics of MB across various implant materials and healthy tissue types.
  • To determine the efficacy of MB in visualizing bacterial biofilms in an in vitro setting.

Main Methods:

  • Biofilms of Staphylococcus aureus and Pseudomonas aeruginosa were cultivated on titanium, cobalt chromium, polyethylene, and PEEK coupons in CDC biofilm reactors.
  • Biofilms were stained with 0.005% or 0.01% methylene blue (MB) solutions, followed by saline washing.
  • Digital photography, scanning electron microscopy (SEM), and ImageJ analysis were used to assess biofilm presence, staining intensity, and species-specific staining.

Main Results:

  • Staphylococcus aureus and Pseudomonas aeruginosa biofilms stained intensely on all tested implant materials (titanium, cobalt chromium, polyethylene, PEEK).
  • Methylene blue (MB) staining was dose-dependent and visible only in the presence of biofilms, confirmed by SEM.
  • While MB stained articular cartilage and meniscus, it did not stain bone, tendon, muscle, nerve, or fat, and did not stain uninoculated controls.

Conclusions:

  • Methylene blue (MB) is a highly effective in vitro disclosing agent for Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
  • MB demonstrated excellent performance on common implant materials, with minimal staining of healthy host tissues.
  • The ability of MB to visualize biofilms may enhance surgical debridement by allowing surgeons to identify infected areas.